Luminopia
Time 2022-09-20 22:57:18Web Name: Luminopia
WebSite: http://www.luminopia.ca
ID:322889
Keywords:
LuminopiaDescription:
For Patients Science About Support Buy Luminopia™ One Log in FDA-approved digital therapeutic for amblyopia. Launching later this year.
My child has amblyopia,
what do we do?
Why addressing amblyopia is important
It leads to missing out in school, sports, work, and everyday life.
It can even cause permanent vision loss.
Your treatment options:
Luminopia™
One
Fun & easy for kids Use 1 hour per day Use for 3-6 months
Eye
Patching
Stigmatizing & uncomfortable Use 2-6 hours per day Use for 12-24+ months
Developed with leading pediatric
ophthalmologists and neuroscientists
Developed with leading pediatric ophthalmologists and neuroscientists
“ Luminopia One is following a path that promises to transform clinical practice.”
“ Luminopia’s novel technologies and innovative approach promise to transform the future of visual care and beyond.”
“ I feel like I’m sitting near Alexander Graham Bell while making the first phone call. This has the potential to change the way we practice medicine.”
“ Combining the principles of synaptic plasticity and amblyopia treatment is a truly exciting prospect!”
My child has amblyopia Why it’s important Your treatment options Doctor’s opinionEvidence-Based Science
Luminopia One is a digital therapeutic built on years of cutting-edge science. Our neuroscience-based approach works by presenting TV and movie content differently to each eye within a kid-friendly virtual reality (VR) headset. Thanks to powerful neural plasticity, this rebalancing approach strengthens visual processing, promotes weaker eye usage, and encourages both eyes to work together properly!
At Luminopia, we place a strong emphasis on rigorous clinical research to show that our products are safe and effective for children. To date, we have conducted several clinical trials on Luminopia One in collaboration with leading hospitals and research institutions across the United States. These studies, including a prospective, randomized controlled trial, have demonstrated the potential for Luminopia One to be an engaging and effective at-home therapy for amblyopia. Luminopia One has been approved by the FDA for prescription use, and is indicated for improvement in visual acuity in amblyopia patients aged 4-7.
View supporting literature
Our Scientific Advisors
Peter J. McDonnell, MD
Director of The Wilmer Eye Institute
David G. Hunter, MD, PhD
Ophthalmologist-in-Chief, Boston Children’s Hospital
Gil Binenbaum, MD, MSCE
Chief of Division of Ophthalmology, Children's Hospital of Philadelphia
Marguerite McDonald, MD, FACS
Clinical Professor of Ophthalmology, New York University Langone Medical Center
Mark Bear, PhD
Professor of Neuroscience at MIT’s Picower Institute for Learning and Memory
View Advisor ProfilesBoard of Directors
Robert Langer, ScD
Institute Professor at MIT; Co-Founder of Moderna; Most cited engineer in history
Michelle Kydd Lee
Chief Innovation Officer for Creative Artists Agency; Co-Founder of TIME’S UP
Jeffrey Dunn
Executive Chairman at Sesame Workshop; Former COO of Nickelodeon Networks
Mark Jacobstein
Chief Business Officer at Immunai; Former Chief User Engagement Officer at Guardant Health
Fun and Easy
Luminopia One works by modifying popular TV shows and movies into therapeutic visual stimuli within a VR headset. With a broad library of beloved content available, all you have to do is pick a video and enjoy as we take care of the rest!
Our Media Partners
Easy to use interface
Our simple software application places you into an immersive world that makes it easy to select content and receive therapy.
Real-time insights
In addition to the therapy, our cloud-based online platform provides insights into your usage, helping you stay on track!
TAGS:Luminopia
<<< Thank you for your visit >>>
Websites to related :
adsHot Websites